Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Sales | 23 | 36 | 22 | 24 | 24 |
| Cost of Goods | N/A | 13 | 1 | 2 | 2 |
| Gross Profit | 23 | 23 | 22 | 22 | 21 |
| Operating Expenses | 674 | 567 | 832 | 148 | 121 |
| Operating Income | -651 | -531 | -810 | -124 | -97 |
| Interest Expense | 0 | 0 | 13 | 35 | 34 |
| Other Income | 5 | -14 | 6 | 0 | 0 |
| Pre-tax Income | -647 | -545 | -817 | -159 | -131 |
| Net Income Continuous | -647 | -545 | -817 | -159 | -131 |
| Net Income | $-647 | $-545 | $-817 | $-159 | $-131 |
| EPS Basic Total Ops | -15.00 | -11.25 | -30.00 | -22.50 | -18.75 |
| EPS Basic Continuous Ops | -15.96 | -9.28 | -31.69 | -22.11 | -18.25 |
| EPS Diluted Total Ops | -15.00 | -11.25 | -30.00 | -22.50 | -18.75 |
| EPS Diluted Continuous Ops | -15.96 | -9.28 | -31.69 | -22.11 | -18.25 |
| EBITDA(a) | $-647 | $-528 | $-806 | $-120 | $-93 |